The preventive effect of Xuebijing injection against cytokine storm for severe patients with COVID-19: A prospective randomized controlled trial
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The preventive effect of Xuebijing injection against cytokine storm for severe patients with COVID-19: A prospective randomized controlled trial
Authors
Keywords
COVID-19, Xuebijing injection, Cytokine storm, Pro-inflammatory cytokines, Immunomodulation, Randomized controlled trial
Journal
European Journal of Integrative Medicine
Volume 42, Issue -, Pages 101305
Publisher
Elsevier BV
Online
2021-01-31
DOI
10.1016/j.eujim.2021.101305
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- (2020) Dawei Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
- (2020) Jasper Fuk-Woo Chan et al. LANCET
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Xuebijing Injection Alleviates Pam3CSK4-Induced Inflammatory Response and Protects Mice From Sepsis Caused by Methicillin-Resistant Staphylococcus aureus
- (2020) Tiantian Li et al. Frontiers in Pharmacology
- Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
- (2020) Xiaobo Yang et al. Lancet Respiratory Medicine
- Pathological findings of COVID-19 associated with acute respiratory distress syndrome
- (2020) Zhe Xu et al. Lancet Respiratory Medicine
- The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China
- (2020) Wen Zhang et al. CLINICAL IMMUNOLOGY
- Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality
- (2020) Chi Zhang et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Coronavirus Disease 2019 (COVID‐19): What we know?
- (2020) Feng He et al. JOURNAL OF MEDICAL VIROLOGY
- New therapeutic opportunities for COVID-19 patients with Tocilizumab: Possible correlation of interleukin-6 receptor inhibitors with osteonecrosis of the jaws
- (2020) Francesco Bennardo et al. ORAL ONCOLOGY
- Core Outcome Set for Clinical Trials of COVID-19 Based on Traditional Chinese and Western Medicine
- (2020) Ruijin Qiu et al. Frontiers in Pharmacology
- Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
- (2020) Bo Diao et al. Frontiers in Immunology
- Combination of western medicine and Chinese traditional patent medicine in treating a family case of COVID-19
- (2020) Li Ni et al. Frontiers of Medicine
- The Society for Immunotherapy of Cancer perspective on regulation of interleukin-6 signaling in COVID-19-related systemic inflammatory response
- (2020) Fernanda I Arnaldez et al. Journal for ImmunoTherapy of Cancer
- Clinical features of severe patients infected with 2019 novel coronavirus: a systematic review and meta-analysis
- (2020) Daozheng Huang et al. Annals of Translational Medicine
- Combined use of the neutrophil-to-lymphocyte ratio and CRP to predict 7-day disease severity in 84 hospitalized patients with COVID-19 pneumonia: a retrospective cohort study
- (2020) Yue-Ping Liu et al. Annals of Translational Medicine
- Potential effectiveness and safety of antiviral agents in children with coronavirus disease 2019: a rapid review and meta-analysis
- (2020) Qianling Shi et al. Annals of Translational Medicine
- Risk factors associated with disease progression in a cohort of patients infected with the 2019 novel coronavirus
- (2020) Yulong Zhou et al. Annals of Palliative Medicine
- Pharmaco-Immunomodulatory Therapy in COVID-19
- (2020) John G. Rizk et al. DRUGS
- The pathogenesis and treatment of the `Cytokine Storm' in COVID-19
- (2020) Qing Ye et al. JOURNAL OF INFECTION
- Prediction of the Severity of the Coronavirus Disease and Its Adverse Clinical Outcomes
- (2020) Xiaohui Liu et al. JAPANESE JOURNAL OF INFECTIOUS DISEASES
- XueBiJing Injection Versus Placebo for Critically Ill Patients With Severe Community-Acquired Pneumonia
- (2019) Yuanlin Song et al. CRITICAL CARE MEDICINE
- Efficacy of Xuebijing Injection for Sepsis (EXIT-SEP): protocol for a randomised controlled trial
- (2019) Songqiao Liu et al. BMJ Open
- The preventive effect of Chinese herbal preparation Xuebijing against hyperactive inflammation after hepato-pancreato-biliary surgery
- (2019) Qifan Zhang et al. Annals of Translational Medicine
- Severe Acute Respiratory Syndrome
- (2019) David S.C. Hui et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology
- (2017) Rudragouda Channappanavar et al. Seminars in Immunopathology
- Immunotherapeutic implications of IL-6 blockade for cytokine storm
- (2016) Toshio Tanaka et al. Immunotherapy
- Xuebijing injection in the treatment of severe pneumonia: study protocol for a randomized controlled trial
- (2016) Ping Wang et al. Trials
- Treatment Effects of Xuebijing Injection in Severe Septic Patients with Disseminated Intravascular Coagulation
- (2014) Qin Yin et al. Evidence-based Complementary and Alternative Medicine
- Xuebijing exerts protective effects on lung permeability leakage and lung injury by upregulating Toll-interacting protein expression in rats with sepsis
- (2014) MING-WEI LIU et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Into the Eye of the Cytokine Storm
- (2012) J. R. Tisoncik et al. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
- C-reactive protein and procalcitonin as predictors of survival and septic shock in ventilator-associated pneumonia
- (2009) G. Hillas et al. EUROPEAN RESPIRATORY JOURNAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started